Browse Topic
Eye Health and Vision Science
-
April 06, 2026Eye drop recall 2026: FDA flags over 3 million bottles; Eye doctors explain what you should know
Over 3 million bottles of eye drops have been recalled. The drops are sold under brand names distributed to nationwide retailers, including Walgreens and CVS.
Read More
-
March 19, 2026Mark Rosenblatt: Exploring new pathways in corneal nerve regeneration
The new vice chancellor of human health sciences leads his own research while also supporting thousands of other researchers in their work.
Read More
-
February 13, 2026
Virtual reality exam checks eye health and screens for early signs of Alzheimer’s
UC Davis researchers are using virtual reality to make eye exams easier for seniors and to investigate whether it can detect early brain changes linked to Alzheimer’s disease.
Read More
-
November 04, 2025Cornea recipient shares journey, gratitude during Eye Donation Month
Christine Lichti, a pediatric critical care nurse, shares how corneal disease affected her vision and how two donors' selfless gifts changed her life.
Read More
-
August 28, 2025Center for Neuroscience names Marie Burns new director
Vision neuroscientist Marie E. Burns has been appointed director of the Center for Neuroscience after serving as interim director for the past year.
Read More -
August 27, 2025Thiran Jayasundera appointed chair of Department of Ophthalmology and Vision Science
Kanishka Thiran Jayasundera has been appointed professor and chair of the Department of Ophthalmology and Vision Science in the UC Davis School of Medicine.
Read More
-
July 22, 2025UC Davis Health receives $3.6 million grant from NIH to improve eye gene therapy
The UC Davis Department of Ophthalmology received a five-year, $3.6 million grant from the National Eye Institute to explore a new way to treat vision loss using gene therapy.
Read More
-
May 01, 2025
Early-stage trial finds stem cell therapy for retinitis pigmentosa is safe
An early-stage trial finds that CD34+ stem cells are a safe — and possibly effective — treatment for vision loss from retinitis pigmentosa.
Read More
-
April 02, 2025UC Davis doctor trains pediatric anesthesiologists in country with critical shortage
Niroop Ravula’s trip to Zambia is part of UC Davis Health’s long-running commitment to global eye health with Orbis International.
Read More
-
February 26, 2025Celebration of the Century: Ernest Tschannen turns 100
Members of the UC Davis Eye Center gathered recently to celebrate the milestone birthday of Ernest E. Tschannen, who turned 100 on February 16th.
Read More
-
July 10, 2024Vision neuroscientist appointed interim director for Center for Neuroscience
Vision neuroscientist Marie Burns has been appointed interim director for the UC Davis Center for Neuroscience.
Read More
-
June 25, 2024Surgery may benefit macular edema from Coats disease
Surgery may benefit patients with Coats disease who do not improve with standard treatments, according to a new case study. The rare eye disorder is often diagnosed in childhood.
Read More
-
May 10, 2024UC Davis Health Ophthalmologist Glenn Yiu honored for retina research
The Association for Research in Vision and Ophthalmology recognized Glenn Yiu, a professor of ophthalmology, with the 2024 Carl Camras Translational Research Award.
Read More
-
April 01, 2024How to protect your eyes during the 2024 solar eclipse
Staring at the sun can damage your eyes in less than a minute. An ophthalmologist explains how to protect your vision during the 2024 eclipse.
Read More
-
December 19, 2023
Are over-the-counter eye drops safe?
Dozens of eye drop recalls have left consumers confused. An expert explains why there have been so many recalls and how to pick safe eye drops.
Read More
-
November 16, 2023
FDA eye drop recall: Don’t use these CVS, Rite Aid, Walmart and Target brands
The FDA is again warning consumers to immediately stop using 27 over-the-counter eye drop products due to the potential risk of eye infections that could result in partial vision loss or blindness.
Read More -
November 13, 2023
Infections from over-the-counter artificial tears: Implications for patients and clinicians
An expert in ophthalmologic product development explains why so many eyedrops have been recalled this year and gives advice for how clinicians can help patients stay safe.
Read More
-
October 13, 2023Ernest E. Tschannen Eye Institute Building recognized regionally and nationally for outstanding design
The Ernest E. Tschannen Eye Institute Building received top awards from the Construction Managers Association of America and the Sacramento Business Journal.
Read More
-
August 29, 2023Eye Center tests experimental gene therapy for wet age-related macular degeneration
An experimental medicine being tested at the UC Davis Eye Center uses gene therapy as a possible treatment for wet age-related macular degeneration or wet AMD.
Read More -
August 25, 2023
FDA warns people not to use 2 types of eye drops due to contamination
The FDA has issued a warning about two types of eye drops, due to possible contamination. The new warning comes after several eye drop recalls this year.
Read More
